Perspectives on Treatment Interventions in Paraphilias

Handbook of Medical Psychiatry

Volumn , Issue , 2003, Pages 909-918

  Thibaut, Florence ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842715290     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203912485-63     Document Type: Chapter

References (56)

1. KL Soothill, TCN Gibbens. Recidivism of sexual offenders: reappraisal. Br J Criminol 18:267-275, 1978.
2. PH Gebhard, JH Gagnon, WB Pomeroy, CV Christeason. Sex Offenders: An Analysis of Types. New York: Harper and Row, 1965, pp 811-812.
3. JMW Bradford. The paraphilias, obsessive compulsive spectrum disorder, and the treatment of sexually deviant behaviour. Psychiatr Q 70(3):209-219, 1999.
4. M Elliott. Female sexual abusers: the ultimate taboo. In: M Elliott, ed. Female Sexual Abusers: The Ultimate Taboo. London: J. Wiley and Sons, 1993.
5. DR Rubinow, PJ Schmidt. Androgens, brain and behavior. Am J Psychiatry 153:974-984, 1996.
6. C Carani, J Bancroft, A Granata, G Del Rio, P Marrama. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men. Psychoneuroendocrinology 17(6): 647-654, 1992.
7. RM Rose, JW Holaday, IS Bernstein. Plasma testosterone, dominance rank and aggressive behaviour in male rhesus monkeys. Nature 231:366-368, 1972.
8. GR Gaffney, FS Berlin. Is there hypothalamic-pituitary-gonadal dysfunction in paedophilia? Br J Psychiatry 145:657-660, 1984.
9. J Bancroft, G Tennent, K Loucas, J Cass. The control of deviant sexual behavior by drugs. I. Behavioral changes following estrogens and antiandrogens. Br J Psychiatry 125:310-315, 1974.
10. AJ Cooper, S Sandhu, S Losztyn, ZZ Cernovsky. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry 37:687-693, 1992.
11. CM Meston, PF Frohlich. The neurobiology of sexual function. Arch Gen Psychiatry 57:1012-1030, 2000.
12. S Stoleru, MC Gregoire, D Gerard, J Decety, E Lafarge, L Cinotti, F Lavenne, D Le Bars, E Vernet-Maury, H Rada, C Collet, B Mazoyer, MG Forest, F Magnin, A Spira, D Comar. Neuroanatomical correlates of visually evoked sexual arousal in human males. Arch Sex Behav 28(1):1-21, 1999.
13. LS Grossman, B Martis, CG Fichter. Are sex offenders treatable? A research overview. Psychiatr Serv 50:349391, 1999.
14. DJ Stein, E Hollander, DT Anthony, FR Schneier, B Fallon, MR Liebowitz, DF Klein. Serotonergic medication of sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry 53:267-271, 1992.
15. L Gijs, L Gooren. Hormonal and psychopharmaco-logical interventions in the treatment of paraphilias: an update. J Sex Res 33(4):273-290, 1996.
16. JMW Bradford, DM Greenberg. Pharmacological treatment of deviant sexual behaviour. Annu Rev Sex Behav 7:283-306, 1996.
17. R Balon. Pharmacological treatment of paraphilias with a focus on antidepressants. J Sex Marital Ther 24:241-254, 1998.
18. E. Coleman, J Cesnik, AM Moore, SM Dwyer. An exploratory study of the role of psychotropic medications in treatment of sexual offenders. J Off Rehab 18:75-88, 1992.
19. MP Kafka. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 6:189-195, 1994.
20. DM Greenberg, JMW Bradford, S Curry, A O’Rourke. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law 24:525-532, 1996.
21. MP Kafka, R. Prentsky. A comparative study of non-paraphilic sexual addictions and paraphilias in men. J Clin Psychiatry 53: 345-350, 1992.
22. MP Kruesi, S Fine, L Valladares, RA Phillips, J Rapoport. Paraphilias : a double bind cross-over comparison of clomipramine versus desipramine. Arch Sex Behav 21:587-593, 1992.
23. P Sterkman, F Geerts. Is benperidol (RF 504) the specific drug for the treatment of excessive and disinhib-ited sexual behaviour? Acta Neurol Psychiatr 66:10301040, 1966.
24. AA Bartholomew. A long-acting phenothiazine as a possible agent to control deviant sexual behavior. Am J Psychiatr 124:917-923, 1968.
25. N Heim, CJ Hursch. Castration for sex offenders: treatment or punishment? A review and critique of recent European literature. Arch Sex Behav 8(3):281-304, 1979.
26. E Eibl. Treatment and after-care of 300 sex offenders, especially with regard to penile plethysmography. Justizministerium Baden-Württemberg. Proceedings of the German Conference on Treatment Possibilities for Sex Offenders in Eppingen, Stuttgart, 1978.
27. JM Bailey, AS Greenberg. The science and ethics of castration: lessons from the Morse case. Northwestern Law Rev 92: 266-277, 1998.
28. LH Whittaker. Estrogens and psychosexual disorders. Med J Aust 2:547-549, 1959.
29. CG Heller, M Laidlaw, HT Harvey, DL Nelson. The effects of the progestational compounds on the reproductive processes of the human male. Ann NY Acad Sci 71:649-655, 1958.
30. HG Gottesman, DS Schubert. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias. J Clin Psychiatry 54(5):182-188, 1993.
31. AL Southren, GG Gordon, J Vittek, K Altman. Effect of progestagens on androgen metabolism. In: L Martini, M Motta, eds. Androgens and antiandrogens. New York: Raven Press, 1977, pp 263-279.
32. J Money. Discussion on hormonal inhibition of libido in male sex offenders. In: RP Michael, ed. Endocrinology and Human Behavior. London: Oxford University Press, 1968, p 169.
33. U Laschet, L Laschet. Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmacopsychiatr Neuropsychopharmacol Adv Clin Res 4:99-110, 1971.
34. AJ Cooper A placebo controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 22:458-465, 1981.
35. TA Kiersch. Treatment of sex offenders with Depo-Provera. Bull Am Acad Psychiatry Law 18:179-187, 1990.
36. JMW Bradford, A Pawlak. Double-blind placebo cross-over study of cyproterone acetate in the treatment of paraphilias. Arch Sex Behav 22:383-402, 1993.
37. A Rosler, E Witztum. Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 18:43-56, 2000.
38. WJ Meyer, CM Cole. Physical and chemical castration of sex offenders: a review. J Off Rehab 25(3/4):1-18, 1997.
39. J Money, C Wiedeking, P Walker, C Migeon, W Meyer, D Borgaonkar. 47,XYY and 46,XY males with antisocial and/or sex-offending behavior: antiandrogen therapy plus counselling. Psychoneuroendocrinology 1:165-178, 1975.
40. R Langevin, D Paitich, S Hucker, S Newman, G Ramsey, S Pope, G Geller, C Anderson. The effect of assertiveness training, Provera, and sex of therapist in the treatment of genital exhibitionism. J Behav Ther Exp Psychiatry 10:275-282, 1979.
41. F Neumann. Pharmacology and potential use of cypro-terone acetate. Horm Metab Res 9:1-13, 1977.
42. AJ Cooper, ZZ Cernovski. Comparison of cyproterone acetate and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry 36(4):269-271, 1994.
43. AJ Cooper, S Swaminath, D Baxter, C Poulin. A female sex offender with multiple paraphilias: a psychological, physiologic (laboratory sexual arousal) and endocrine case study. Can J Psychiatry 35:334337, 1990.
44. PT Loosen, SE Purdon, SN Pavlou. Effects on behavior of modulation of gonadal function in men with gonadotrophin releasing hormone antagonists. Am J Psychiatry 151:271-273, 1994.
45. KM Kendrick, AF Dixson. Luteinizing hormone releasing hormone enhances proceptivity in a primate. Neuroendocrinology 41:449-453, 1985.
46. RL Moss, CA Dudley. Luteinizing hormone-releasing hormone (LHRH): peptidergic signals in the neural integration of female reproductive behavior. In: JM Lakoski, JR Perez-Polo, DK Rassin, eds. Neural Control of Reproductive Function. New York: Liss, 1989, pp 485-499.
47. T Kadar G Telegdy, AV Schally. Behavioral effects of centrally administered LH-RH agonist in rats. Physiol Behav 50:601-605, 1992.
48. L Rousseau, M Couture, A Dupont, F Labrie, N Couture. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry 35:338-341, 1990.
49. R Dickey. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 37:567-569, 1992.
50. F Thibaut, B Cordier, JM Kuhn. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 87:445-450, 1993.
51. A Rosler, E Witztum. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 338:416-422, 1998.
52. TS Davies. Cyproterone acetate for male hypersexuality. J Int Med Res 2:159-163, 1974.
53. F Thibaut, B Cordier, JM Kuhn. Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 21(4):411-419, 1996.
54. JM Bradford. Organic treatment for the male sexual offender. Ann NY Acad Sci 528:193-202, 1998.
55. F Thibaut, JM Kuhn, B Cordier, M Petit. Les traitements hormonaux de la delinquance sexuelle. Encephale XXIV:132-137, 1998.
56. RK Hanson, MT Bussiere. Predicting relapse: a metaanalysis of sexual offender recidivism studies. J Consult Clin Psychol 66:348-362, 1998.